Abcellera Biologics Inc ABCL

$13.92 +1.22 (9.61%)

Valuation

Market cap
3,893,960,000
Revenue TTM
$75,130,000
Net income TTM
$-146,410,000
PE ratio
0.00
Forward PE
—
Profit margin
-194.88%
Debt to equity
0.00

Trading

Volume
7,824,200
Avg volume
6,910,410
Day's range
$12.38 – $14.23
Shares out
306,611,000
Stochastic %K
90%
Beta
1.32
Analysts
Strong Sell
Price target
$16.67

Price

Company profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-medi...

Show more

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; Jazz Pharmaceuticals plc to develop T-cell engaging (TCE) multispecific antibodies; partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc.; and Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases and other conditions. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
604 559 9005
Website
https://www.abcellera.com
Address
150 W 4th Avenue, Vancouver, Canada

Latest news

Stocktwits

History101 Sep 28, 11:05 PM
$ABCL LOL ABCL is up 199% since this smart guy's post:
0 replies
PLTRLONGDONG Sep 28, 10:29 PM
$ABCL $26 near term PT $111 5 year PT
0 replies
MadStockAlerts1 Sep 28, 9:49 PM
$ABCL ran hard, then just went quiet. That tight sideways chop after a sharp move is a bull flag, and it's the kind of setup that we like to see
0 replies
topstockalerts Sep 28, 9:34 PM
$ABCL this has that “don’t overthink it” look.
0 replies
Jwa68 Sep 28, 9:26 PM
$ABCL Nice tape. As expected.
0 replies
ITF Sep 28, 9:12 PM
$ABCL i've written before about my sort pt expectations and resistance points , i want to add that if All ABCL potential (5-10 year)will be accounted for in this Rally we could see an explosion between 36-52 followed by a huge dip afterwards(low percentage for this but ABCL potential is massive to say the least it's a matter of time (success driven , both internal programs + external partnerships ) that could make this 100+ dollar stock by 2029
0 replies
Odoji Sep 28, 9:09 PM
$ABCL 💉
0 replies
Gurufatcat Sep 28, 9:00 PM
$ABCL it’s going to burst buckle up
0 replies